The World Health Organization (WHO) defines obesity as abnormal or excessive fat accumulation in the body that may adversely affect health. In 2022, 1 in 8 people worldwide lived with obesity, while the adult obesity rate has more than doubled since 1990, and the adolescent obesity rate has quadrupled. Obesity is a risk factor for noncommunicable diseases such as type 2 diabetes, hypertension, cardiovascular diseases, cancer, and sleep apnea, and is associated with an increased risk of death. The treatment of obesity-related comorbidities, along with indirect costs resulting from lost productivity and premature death, contributes to the economic burden caused by obesity. Therefore, effective management of obesity is of critical importance for improving overall health outcomes and reducing the burden on healthcare systems. It has been demonstrated that a 5% reduction in body weight in individuals diagnosed with obesity can improve health outcomes, and this value has been established as a target standard for weight loss interventions. However, while dietary interventions can achieve clinically meaningful weight loss, weight regain is common due to a combination of low adherence to dietary strategies and compensatory physiological mechanisms that influence weight regain. Consequently, individuals may find themselves in a "weight cycle," losing weight and then regaining it. Weight maintenance is defined as intentional weight loss followed by the preservation of that loss for at least six months. It has been noted that the weight cycle complicates this process. The weight cycle defined as repeated periods of intentional weight loss followed by regain is considered a common yet poorly understood factor among obese individuals. The weight cycle is viewed as one of the major challenges in clinical obesity care. For this reason, it is emphasized that strategies aimed at preventing weight cycling or promoting weight maintenance have gained importance. Additionally, attention is drawn to psychological factors in eating behavior, with particular emphasis on the individual's self-confidence and stress levels being crucial for sustaining healthy eating behaviors. Individuals experiencing weight cycling often face challenges with diet adherence, sustainability, and stress management. Meal frequency strategies applied to these individuals can influence not only weight loss but also diet adherence and the psychological experience of the dietary process. Given the rise in obesity and obesity-related disorders, understanding the relationship between stress, self-efficacy, and food choice in young adulthood may offer insights into preventing adverse health outcomes in later life stemming from poor dietary habits. An appropriate meal schedule can help an individual adapt better to the diet and manage the process with less stress; thereby facilitating weight maintenance success and making healthy eating a lifestyle. However, in the treatment of obesity, data regarding different meal frequency approaches in dietary interventions remain controversial. The aim of this study is to examine the factors influencing the sustainability of the diet and the long-term maintenance of weight loss in individuals experiencing weight cycling. In this context, the effects of different meal frequencies on this process were evaluated; the study addressed not only physical outcomes but also psychological factors such as how individuals felt during the dietary process, their stress levels, and their self-confidence. Thus, the aim was to present a more comprehensive perspective by examining the relationship between meal frequency and weight management from both physiological and psychological dimensions.
Age range
25 Years – 55 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Body weight (kg)
Timeframe: Baseline, Weeks 2, 4, 6, and 8, and 6 months post-intervention
Body mass index (kg/m²)
Timeframe: Baseline, Weeks 2, 4, 6, and 8, and 6 months post-intervention
Height (cm)
Timeframe: Baseline, Weeks 2, 4, 6, and 8, and 6 months post-intervention
Waist circumference (cm)
Timeframe: Baseline, Weeks 2, 4, 6, and 8, and 6 months post-intervention
Hip circumference (cm)
Timeframe: Baseline, Weeks 2, 4, 6, and 8, and 6 months post-intervention
Neck circumference (cm)
Timeframe: Baseline, Weeks 2, 4, 6, and 8, and 6 months post-intervention
waist-to-height ratio
Timeframe: Baseline, Weeks 2, 4, 6, and 8, and 6 months post-intervention
waist-to-hip ratio
Timeframe: Baseline, Weeks 2, 4, 6, and 8, and 6 months post-intervention
basal metabolic rate (kcal)
Timeframe: Baseline, Weeks 2, 4, 6, and 8, and 6 months post-intervention
Body Fat mass (kg)
Timeframe: Baseline, Weeks 2, 4, 6, and 8, and 6 months post-intervention
Lean body mass (kg)
Timeframe: Baseline, Weeks 2, 4, 6, and 8, and 6 months post-intervention
Percentage of lean body mass(%)
Timeframe: Baseline, Weeks 2, 4, 6, and 8, and 6 months post-intervention
Body fat percentage (%)
Timeframe: Baseline, Weeks 2, 4, 6, and 8, and 6 months post-intervention
Total body water (L)
Timeframe: Baseline, Weeks 2, 4, 6, and 8, and 6 months post-intervention
Lipid accumulation product index-LAP
Timeframe: Baseline, Week 8 and 6 months post-intervention
Visceral adiposity index-VAI
Timeframe: Baseline, Week 8 and 6 months post-intervention
Conicity index - CI
Timeframe: Baseline, Week 8 and 6 months post-intervention
A body shape index-ABSI
Timeframe: Baseline, Week 8 and 6 months post-intervention
Abdominal volume index-AVI
Timeframe: Baseline, Week 8 and 6 months post-intervention
Body adiposity index-BAI
Timeframe: Baseline, Week 8 and 6 months post-intervention
Body roundness index-BRI
Timeframe: Baseline, Week 8 and 6 months post-intervention
Anthropometric risk index-ARI
Timeframe: Baseline, Week 8 and 6 months post-intervention
Fasting blood glucose (mg/dL)
Timeframe: Baseline, Week 8 and 6 months post-intervention
Triglycerides (mg/dL)
Timeframe: Baseline, Week 8 and 6 months post-intervention
Total cholesterol (mg/dL)
Timeframe: Baseline, Week 8 and 6 months post-intervention
HDL cholesterol (mg/dL)
Timeframe: Baseline, Week 8 and 6 months post-intervention
LDL cholesterol (mg/dL)
Timeframe: Baseline, Week 8 and 6 months post-intervention
Thyroid stimulating hormone (TSH) (µIU/mL)
Timeframe: Baseline, Week 8 and 6 months post-intervention
Alanine aminotransferase (ALT) (U/L)
Timeframe: Baseline, Week 8 and 6 months post-intervention
Aspartate aminotransferase (AST) (U/L)
Timeframe: Baseline, Week 8 and 6 months post-intervention